Immunity to the protozoan Trypanosoma cruzi is complex, involving multiple immune effector mechanisms operating at several levels of the infection. In this study we propose to continue investigation of how immunity to T. cruzi is regulated, with special focus on the. generation, development and maintenance of T cell responses, particularly CD8+ T cell responses which are crucial to the recognition and control of T. cruzi at the level of the infected host cell. Using a panel of newly identified immunodominant and subdominant epitopes from trans-sialidase proteins and MHC-peptide tetramers recognizing the T cells specific for these epitopes, as well as methods for the monitoring of the overall T. cruzi-specific T cell response, we will follow the very earliest events in the development of parasite-specific T cells in an attempt to determine why initial generation of these responses is delayed until 8-10 days post-infection. A complete analysis of the frequency, phenotype and functional activity of parasite-specific T cells, with a strong emphasis on the CDS T cells, will also be conducted with the ultimate goal of determining if parasite persistence leads to a stable effector/memory population or to a state of """"""""antigen-addicted exhaustion"""""""". A newly developed drug treatment/cure model will be used to compare the status of immunological memory that develops in the presence and absence of parasite persistence. The mechanisms by which T. cruzi -specific CD8+ T cells are regulated in muscle tissue will be investigated, highlighting the possible role of PD-1/PD-L1 induced immunoregulation, the trafficking of T cells to muscle, and the role of antigen exposure in T cell suppression/ exhaustion in muscle and other sites of antigen persistence. Lastly the potential to use boosting of immunodominant or subdominant epitope-specific CD8+ T cell responses to achieve better control and perhaps cure of the infection will be investigated. Because of our ability to follow true parasite specific responses in vivo and directly ex vivo and from the very earliest time point into the chronic disease state, these studies will be unique among parasite systems. The results of these studies also have strong parallels with human T. cruzi infection and implications for possible treatment of infection and disease in infected subjects. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI022070-19
Application #
7428857
Study Section
Pathogenic Eukaryotes Study Section (PTHE)
Program Officer
Wali, Tonu M
Project Start
1985-09-30
Project End
2012-05-31
Budget Start
2008-06-01
Budget End
2009-05-31
Support Year
19
Fiscal Year
2008
Total Cost
$361,744
Indirect Cost
Name
University of Georgia
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
004315578
City
Athens
State
GA
Country
United States
Zip Code
30602
Rosenberg, Charles S; Zhang, Weibo; Bustamante, Juan M et al. (2016) Long-Term Immunity to Trypanosoma cruzi in the Absence of Immunodominant trans-Sialidase-Specific CD8+ T Cells. Infect Immun 84:2627-38
Kurup, Samarchith P; Tarleton, Rick L (2014) The Trypanosoma cruzi flagellum is discarded via asymmetric cell division following invasion and provides early targets for protective CD8? T cells. Cell Host Microbe 16:439-49
Kurup, Samarchith P; Tarleton, Rick L (2013) Perpetual expression of PAMPs necessary for optimal immune control and clearance of a persistent pathogen. Nat Commun 4:2616
Collins, Matthew H; Craft, Julie M; Bustamante, Juan M et al. (2011) Oral exposure to Trypanosoma cruzi elicits a systemic CD8? T cell response and protection against heterotopic challenge. Infect Immun 79:3397-406
Bustamante, Juan M; Tarleton, Rick L (2011) Methodological advances in drug discovery for Chagas disease. Expert Opin Drug Discov 6:653-661
Martin, Diana L; Murali-Krishna, Kaja; Tarleton, Rick L (2010) Generation of Trypanosoma cruzi-specific CD8+ T-cell immunity is unaffected by the absence of type I interferon signaling. Infect Immun 78:3154-9
Rosenberg, Charles S; Martin, Dianya L; Tarleton, Rick L (2010) CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance. J Immunol 185:560-8
Padilla, Angel M; Bustamante, Juan M; Tarleton, Rick L (2009) CD8+ T cells in Trypanosoma cruzi infection. Curr Opin Immunol 21:385-90
Padilla, Angel M; Simpson, Laura J; Tarleton, Rick L (2009) Insufficient TLR activation contributes to the slow development of CD8+ T cell responses in Trypanosoma cruzi infection. J Immunol 183:1245-52
Bustamante, Juan M; Bixby, Lisa M; Tarleton, Rick L (2008) Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease. Nat Med 14:542-50

Showing the most recent 10 out of 45 publications